Luiz Pimentel

7PUBLICATIONS
10CO-AUTHORS
Molecular targetsInnate immunityTumour immunologyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 14, 2026
Hybrid Isatin and Imatinib Analogues as Potential Antineoplastic Agents.

|Oct 26, 2024
Ponatinib: A Review of the History of Medicinal Chemistry behind Its Development.

Mayara Nascimento, Stefany Moura, Lidia Parra

|Apr 16, 2024
Spirooxadiazoline-oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells.

Liviane D de Azevedo, Debora I Leite, Andressa P de Oliveira

|Apr 28, 2023
A Review of the Development of Multitarget Molecules against HIV-TB Coinfection Pathogens.

Debora Inacio Leite, Stefany de Castro Bazan Moura, Maria da Conceição Avelino Dias

|Mar 26, 2022
Hybrids of Imatinib with Quinoline: Synthesis, Antimyeloproliferative Activity Evaluation, and Molecular Docking.

Carine Santos, Luiz Pimentel, Henayle Canzian

|Feb 15, 2022
New Imatinib Derivatives with Antiproliferative Activity against A549 and K562 Cancer Cells.

Andressa Oliveira, Stefany Moura, Luiz Pimentel

Pageof 2

Frequent Collaborators

5 joint publications

Nubia Boechat

2 joint publications

Anna Cunha

2 joint publications

Maria Dias

2 joint publications

Tácio Vinício Amorim Fernandes